Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Rui Chang
Associate Professor, Neurology | Member of the Graduate Faculty
Neurology
Overview
Research
More
Collaboration
(15)
Kathleen Rodgers
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Phillip Kuo
Mutual work: 2 Grants﹒2 Proposals
Collaboration Details
Alex Hishaw
Mutual work: 1 Proposal
Collaboration Details
Theodore Trouard
Mutual work: 2 Grants﹒2 Proposals
Collaboration Details
Roberta Brinton
Mutual work: 1 Grant﹒2 Proposals﹒1 Tech
Collaboration Details
Page 1 of 3
Previous page
Next page
Grants
(12)
Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias
Active
·
2023
·
$55.1K / $275.7K
·
External
Co-Investigator (COI)
alzheimer disease,
natural products,
dementia,
treatment,
combinations
Applying Pathomics to Establish a Biosignature for Aggressive Skin Melanoma
Active
·
2022
·
$423.4K
·
External
Principal Investigator (PI)
pathomics,
biosignature,
skin melanoma,
aggressive,
establish
A prognostic mRNA immune Signature for Resected Stage II-III Melanoma
Active
·
2022
·
$76.8K / $153.5K
·
External
Principal Investigator (PI)
mrna immune signature,
melanoma,
prognostic,
resected,
stage ii-iii
A prognostic mRNA immune Signature for Resected Stage II-III Melanoma
Active
·
2022
·
$76.8K
·
External
Principal Investigator (PI)
mrna immune signature,
melanoma,
prognostic,
resected,
stage ii-iii
Core F- AZ Alzheimer's Disease Research Center--Biomarker/Clinical/Data Management & Statistics Cores
Active
·
2021
·
$34.7K / $733.8K
·
External
Co-Investigator (COI)
alzheimer's disease,
biomarker,
clinical,
data management,
statistics
Page 1 of 3
Previous page
Next page
Publications
(61)
Recent
Predictive metabolic networks reveal sex‐ and APOE genotype‐specific metabolic signatures and drivers for precision medicine in Alzheimer's disease
2023
metabolic networks,
precision medicine,
alzheimer's disease,
sex-specific,
apoe genotype
Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer’s disease
2023
alzheimer's disease,
predictive network analysis,
jmjd6,
key drivers,
potential
Novel Master Regulators of Microglial Phagocytosis and Repurposed FDA-approved Drug for Treatment of Alzheimer Disease
2022
alzheimer disease,
microglial phagocytosis,
master regulators,
drug repurposing,
fda-approved drug
Predictive metabolic networks reveal sex and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer Disease
2022
metabolic networks,
precision medicine,
alzheimer disease,
sex-specific metabolism,
apoe genotype
Predictive Network Analysis Identifies JMJD6 and Other Novel Key Drivers in Alzheimer’s Disease
2022
alzheimer's,
network analysis,
jmjd6,
predictive analysis,
key drivers
Novel Inhibitors against COVID-19 main protease suppressed viral infection
2022
covid-19,
protease inhibitors,
viral infection,
novel inhibitors,
viral protease
Culture shock: microglial heterogeneity, activation, and disrupted single-cell microglial networks in vitro
2022
microglial heterogeneity,
activation,
single-cell microglial networks,
culture shock,
in vitro
Novel Master Regulators of Microglial Phagocytosis and Repurposed FDA-Approved Drug for Treatment of Alzheimer's Disease
2022
microglial phagocytosis,
alzheimer's disease,
fda-approved drug,
master regulators,
drug repurposing
Systems and methods for predictive network modeling for computational systems, biology and drug target discovery
2021
predictive modeling,
computational biology,
drug discovery,
network modeling,
systems biology
Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders
2021
transcriptomic analysis,
gene expression,
actinic keratoses,
imiquimod treatment,
treatment responders